Please check your internet connection and try again.
## Diadzein, Genistein, and Palmitoylethanolamide (PEA)
### Overview
This request pertains to a combination of three compounds: diadzein, genistein (both isoflavones found in soy), and palmitoylethanolamide (PEA), a fatty acid amide. These are often marketed as dietary supplements.
### Primary Indications
There are no FDA-approved indications for this combination. These compounds are explored for various purported benefits, including but not limited to:
* Menopausal symptom management (genistein, diadzein)
* Bone health (genistein, diadzein)
* Anti-inflammatory effects (PEA)
* Pain management (PEA)
### Adult Dosing
Dosing for these supplements is highly variable and not standardized. Typical supplemental doses found in over-the-counter products are:
* **Diadzein/Genistein:** Often found in combination products with doses ranging from **20 mg to 80 mg total isoflavones daily**. Individual component doses are not always specified.
* **Palmitoylethanolamide (PEA):** Doses commonly range from **300 mg to 1200 mg daily**, often divided into multiple doses.
Specific dosing for this combination is not established in clinical practice guidelines.
### Pediatric Dosing
There is **no established pediatric dosing** for diadzein, genistein, or palmitoylethanolamide, either individually or in combination. Use in children is not recommended without direct medical supervision.
### Dose Adjustments
No specific dose adjustments are established for renal or hepatic impairment.
### Contraindications
* Hypersensitivity to any component of the preparation.
* Individuals with hormone-sensitive cancers (e.g., breast, uterine, ovarian cancer) should exercise caution and consult with their oncologist due to the potential phytoestrogenic activity of genistein and diadzein.
### Adverse Effects
Adverse effects are generally mild and uncommon but may include:
* **Diadzein/Genistein:** Gastrointestinal upset (nausea, diarrhea), headache, skin rash.
* **Palmitoylethanolamide (PEA):** Generally well-tolerated. Rare reports of gastrointestinal upset.
### Key Drug Interactions
* **Hormone Replacement Therapy (HRT):** Potential for additive or opposing effects.
* **Tamoxifen and other SERMs:** Phytoestrogens may interact with estrogen receptor pathways.
* **Anticoagulants/Antiplatelets:** Some isoflavones may have mild antiplatelet effects; caution with concomitant use.
There is limited formal drug interaction data for this combination.
### Monitoring
* Monitor for intended therapeutic effects and any adverse reactions.
* Individuals with a history of hormone-sensitive conditions should be closely monitored by their healthcare provider.
### Clinical Pearls
* These products are dietary supplements and are not regulated by the FDA for safety and efficacy in the same way as prescription medications.
* The bioavailability and efficacy of these compounds can vary significantly between products and individuals.
* Consultation with a healthcare provider is recommended before starting any new supplement, especially if you have underlying health conditions or are taking other medications.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and clinical guidelines, and exercise your professional judgment when making clinical decisions. The safety and efficacy of this combination have not been established by the FDA.*
